Patent details

Basic Information

Publication number:

92301

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP989368477

Legal Status:

Lapsed

Application number:

92301

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/07/433/002 - NJEVANAC - nepafenac

Marketing Authorization Type:

Marketing Authorization Date:

03/05/2013

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Dates

Filing date:

31/10/2013

First Marketing Authorization date:

03/05/2013

Grant date:

31/12/2013

Activation date:

17/07/2018

Publication date:

31/12/2013

Lapsed date:

Expiration date:

Renunciation date:

16/09/2020

Revocation date:

Annulment date:

Basic SPC Expiration:

17/07/2023

SPC Extension Expiration:

17/07/2023

Rejection date:

Withdrawal date:

Owner

From:

12/12/2019

 

 

Name:

Novartis AG

Address:

., 4002, Basel, Switzerland (CH)

History of Owners

From:

12/12/2019

To:

12/12/2019

Name:

Alcon Vision, LLC

Address:

6201 South Freeway, 76134, Fort Worth, TX, United States (US)

From:

31/10/2013

To:

12/12/2019

Name:

ALCON LABORATORIES INC.

Address:

6201 South Freeway, Fort Worth Texas 76134-2099, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

31/10/2013

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

Name:

ASGHARIAN Bahram

Address:

United States (US)

Publication

Bulletin

1

Bulletin Heading:

SPC3

Bulletin edition number:

2018/09

Publication date:

23/08/2018

Description:

Section E : Supplementary Protection certificates entered into force – IA publication

2

Bulletin Heading:

CO

Bulletin edition number:

2020/01

Publication date:

13/01/2020

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

3

Bulletin Heading:

CO

Bulletin edition number:

2020/01

Publication date:

13/01/2020

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

4

Bulletin Heading:

MED

Bulletin edition number:

2020/11

Publication date:

02/10/2020

Description:

Section K : Modifications and recordals into the register

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20190000460A

Date Registered:

12/12/2019

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Fusion-Absorption

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Alcon Vision, LLC

Address:

6201 South Freeway, 76134, Fort Worth, TX, United States (US)

Removed Pledgee

Name:

Address:

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20190000460B

Date Registered:

12/12/2019

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Novartis AG

Address:

., 4002, Basel, Switzerland (CH)

Removed Pledgee

Name:

Address:

Surrender

Change Kind/ Decision Type:

Total - Renunciation

Deed Number:

RC20200000311A

Date Registered:

16/09/2020

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

02/08/2021

Annual Fee Number:

24

Annual Fee Amount:

440 Euro

Expected Payer:

Last Annual Fee Payment Date:

10/07/2020

Last Annual Fee Paid Number:

23

Last Annual Fee Paid Amount:

430 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
22/09/2020	Outgoing Correspondence	1
16/09/2020	Request For Change	1
12/12/2019	Request For Change	9